Core Laboratories (CLB) Expected to Announce Earnings on Wednesday

Core Laboratories (NYSE:CLB) is expected to be issuing its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect Core Laboratories to post earnings of $0.20 per share and revenue of $130.4020 million for the quarter. Individuals can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 5, 2026 at 8:30 AM ET.

Core Laboratories Trading Up 1.9%

NYSE CLB opened at $19.68 on Wednesday. Core Laboratories has a 12 month low of $9.72 and a 12 month high of $20.36. The stock has a 50-day simple moving average of $17.05 and a 200 day simple moving average of $14.10. The company has a current ratio of 2.37, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $916.30 million, a PE ratio of 29.37, a P/E/G ratio of 16.86 and a beta of 1.03.

Institutional Investors Weigh In On Core Laboratories

Several hedge funds and other institutional investors have recently modified their holdings of the company. Platinum Investment Management Ltd. raised its position in shares of Core Laboratories by 3.9% during the third quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company’s stock worth $294,000 after acquiring an additional 889 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in Core Laboratories by 6.2% in the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock worth $207,000 after purchasing an additional 1,040 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Core Laboratories by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock worth $418,000 after purchasing an additional 1,170 shares during the last quarter. Quarry LP lifted its position in Core Laboratories by 118.1% during the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after purchasing an additional 1,599 shares during the period. Finally, Sei Investments Co. boosted its stake in shares of Core Laboratories by 12.7% in the 3rd quarter. Sei Investments Co. now owns 22,643 shares of the oil and gas company’s stock valued at $280,000 after purchasing an additional 2,550 shares during the last quarter. Institutional investors own 97.81% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Core Laboratories in a research report on Monday, December 29th. Four equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Core Laboratories presently has an average rating of “Hold” and an average price target of $12.50.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.